Analysis of Direct Medical Costs on Type 2 Diabetes Mellitus Outpatient with Cardiovascular Disease

  • Home
  • Analysis of Direct Medical Costs on Type 2 Diabetes Mellitus Outpatient with Cardiovascular Disease

Analysis of Direct Medical Costs on Type 2 Diabetes Mellitus Outpatient with Cardiovascular Disease

1Wahyudi Wahyudi, 2Siti Nurhaliza Fardani, 3Vina Noura, Dyva Patricia Siahaan, 4Fifia El Zuhra, 5Azzahra Al Adawiyah
1,2,3,4,5Faculty of Public Health, Universitas Islam Negeri Sumatera Utara, Sumatera Utara, Indonesia


ABSTRACT:

T2DM is a chronic disease characterized by high blood glucose levels due to insulin resistance or insufficient insulin production. Aim of this study was to analyze the direct medical costs of outpatient T2DM management with cardiovascular disease complications. 58 T2DM patients at the Universitas Sumatera Utara Hospital, in Sumatera Utara, Indonesia were recruited in this study in April-May 2023. This study analyze based on payer prespective named as Badan Penyelenggara Jaminan Sosial (BPJS). This quantitative research was carried out by collecting data retrospectively. Result of this study show that phycian service IDR 8,715,000, drug acquisition cost IDR 13,081,242, laboratory examination IDR 2,531,000, medical execution IDR 410,000, and administration IDR 1,425,000. Conclusion of this study, that drug acquisition cost was the highest cost IDR 13,081,242.

 

KEYWORDS :

Cardiovascular, Direct Medical Cost, Outpatient, T2DM

 

REFERENCES :

1) Ambarsari, M. P., & Nur Soemah, E. (2023). Analisis Asuhan Keinawatan Pada Pasien DMT 2 dengan Masalah Ketidakstabilan Kadar Glukosa Darah Melalui Pemberian Intervensi Edukasi Diet di Ruang Ixia RSUD Ibnu Sina Gresik (Doctoral Dissertation).
2) Anjani, B., & Harlianti, M. S. (2019). Analisis Efektivitas Biaya (Cost-Effectiveness) Antihiintensi Pada Pasien Hiintensi Komplikasi DMT 2Rawat Inap di RSUD Dr. Moewardi Tahun 2017 (Doctoral dissertation, Universitas Muhammadiyah Surakarta).
3) Badedi, M., Darraj, H., Hummadi, A., Najmi, A., Solan, Y., Zakry, I., & Haddad, E. (2020). Khat chewing and type 2 diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity, 307-312.
4) Bellary, S., Kyrou, I., Brown, J. E., & Bailey, C. J. (2021). Type 2 diabetes mellitus in older adults: clinical considerations and management. Nature Reviews Endocrinology, 17(9), 534-548.
5) Da Costa Nunes, C. F., Yuniarti, T., & Darwati, L. E. (2022, May). The Effect of Diet Hyintension on the Event of Hyintension in the Elderly. In Proceedings of the International Conference on Nursing and Health Sciences (Vol. 3, No. 1, pp. 111-118).
6) Fitria, N., Andela, M., Syaputri, Y. Z., & Nasif, H. (2023). Analisis Efektivitas Biaya Penggunaan Metformin-Glimepiride Terhadap Penurunan Kadar Gula Darah Puasa Pada Pasien DMT 2di RS Universitas Andalas. JSFK (Jurnal Sains Farmasi & Klinis), 9 (sup), 202-207.
7) Istichomah, I. (2020). Penyuluhan kesehatan tentang hiintensi pada lansia di Dukuh Turi, Bambanglipuro, Bantul. Jurnal Pengabdian Harapan Ibu (JPHI), 2(1), 24-29.
8) Leander, D. J., & Tahapary, D. L. (2021). Pemilihan Obat Antidiabetik Oral pada Pasien DMT 2dengan Risiko Tinggi untuk Kejadian Kardiovaskular. Jurnal Penyakit dalam Indonesia, 7(4), 240-248.
9) Lukman, L., Aguscik, A., & Agustin, V. A. (2023). Penerapan Manajemen Nutrisi Pada Asuhan Keinawatan DMT 2 dengan Masalah Keinawatan Defisit Nutrisi. Jurnal ‘Aisyiyah Medika, 8(1).
10) Marasabessy, B. N., dkk. (2020). Pencegahan Penyakit Diabetes Melitus (Dm) Tipe 2. Jawa Tengah: Penerbit NEM.
11) Marniati, A. D., SE, M. K., & Notoatmodjo, S. (2022). Lifestyle of determinant: Penderita penyakit jantung koroner. PT. RajaGrafindo Insada-Rajawali Ins.
12) Masruroh, E. (2018). Hubungan umur dan status gizi dengan kadar gula darah penderita DMT 2. Jurnal Ilmu Kesehatan, 6(2).
13) Putri, R. E. K., Darmawan, E., & Inwitasari, D. A. (2019). Cost of Illness DMT 2dan Komplikasinya pada Peserta Jaminan Kesehatan Nasional (JKN) di Rawat Jalan Rumah Sakit Condong Catur Yogyakarta. Pharmacon: Jurnal Farmasi Indonesia, 16(2), 89-101.
14) Rahayuningsih, N. (2018, August). Evaluasi Penggunaan Obat AntiDMT 2Komplikasi Hiintensi pada Pasien Rawat Inap Di RSUD dr. Soekardjo Kota Tasikmalaya. In Prosiding Seminar Nasional dan Penelitian Kesehatan 2018 (Vol. 1, No. 1).
15) Roeters van Lennep, J. E., Tokgözoğlu, L. S., Badimon, L., Dumanski, S. M., Gulati, M., Hess, C. N., … & Benn, M. (2023). Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society. European heart journal, 44(39), 4157-4173.
16) Sabermahani, A., Sirizi, M. J., Zolala, F., & Nazari, S. (2021). Out-of-pocket costs and importance of nonmedical and indirect costs of inpatients. Value in Health Regional Issues, 24, 141-147.
17) Safitri, S., Lestari, I. P., & Fitri, N. (2023). Pengaruh Pemberian Rebusan Daun Kelor (Moringa Oleifera) terhadap Penurunan Kadar Glukosa Darah pada Lansia DM Tipe 2. Jurnal Penelitian Inawat Profesional, 5(2), 657-666.
18) Sari, L. S. (2017). Analisis biaya akibat sakit serta kualitas hidup pasien DMT 2dengan penyakit jantung. Jurnal Ekonomi Kesehatan Indonesia, 1(3).
19) Setiawan, M. (2021). Sistem Endokrin dan DMT . Jawa Timur: UMM Press.
20) Tandah, MR, Janna, RR, Mallisa, T., & Diana, K. (2023). Analisis Biaya Medis Langsung Dan Tarif Ina-Cbg’s Pasien Diabetes Melitus Tidak Tergantung Insulin Di Rsud Anutapura Palu. Jurnal Ilmiah Ibnu Sina, 57-70.
21) Tiara, U. I. (2020). Hubungan obesitas dengan kejadian hiintensi. Journal of Health Science and Physiomanagement, 2(2), 167-171.
22) Wahyuni, R. T., Witcahyo, E., & Herawati, Y. T. (2023). Hubungan karakteristik pasien, prosedur, dan penyakit penyerta dengan biaya langsung medis pada pasien rawat inap jantung koroner. Jurnal Ekonomi Kesehatan Indonesia, 8(1), 1-10.

  • Share

Leave a Reply

Your email address will not be published. Required fields are marked *